These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 32224441)

  • 1. Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.
    Thiele GM; Duryee MJ; Hunter CD; England BR; Fletcher BS; Daubach EC; Pospisil TP; Klassen LW; Mikuls TR
    Int Immunopharmacol; 2020 Jun; 83():106433. PubMed ID: 32224441
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enrichment of malondialdehyde-acetaldehyde antibody in the rheumatoid arthritis joint.
    Mikuls TR; Duryee MJ; Rahman R; Anderson DR; Sayles HR; Hollins A; Michaud K; Wolfe F; Thiele GE; Sokolove J; Robinson WH; Lingampalli N; Nicholas AP; Talmon GA; Su K; Zimmerman MC; Klassen LW; Thiele GM
    Rheumatology (Oxford); 2017 Oct; 56(10):1794-1803. PubMed ID: 28957552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Malondialdehyde-acetaldehyde adducts and anti-malondialdehyde-acetaldehyde antibodies in rheumatoid arthritis.
    Thiele GM; Duryee MJ; Anderson DR; Klassen LW; Mohring SM; Young KA; Benissan-Messan D; Sayles H; Dusad A; Hunter CD; Sokolove J; Robinson WH; O'Dell JR; Nicholas AP; Tuma DJ; Mikuls TR
    Arthritis Rheumatol; 2015 Mar; 67(3):645-55. PubMed ID: 25417811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peptidyl arginine deiminase expression and macrophage polarization following stimulation with citrullinated and malondialdehyde-acetaldehyde modified fibrinogen.
    Aripova N; Duryee MJ; Hunter CD; Ryan EM; Daubach EC; Jones SQ; Bierman MM; Ragland AS; Mitra A; England BR; Romberger DJ; Thiele GM; Mikuls TR
    Int Immunopharmacol; 2022 Sep; 110():109010. PubMed ID: 35785731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Citrullinated and malondialdehyde-acetaldehyde modified fibrinogen activates macrophages and promotes an aggressive synovial fibroblast phenotype in patients with rheumatoid arthritis.
    Aripova N; Duryee MJ; England BR; Hunter CD; Mordeson JE; Ryan EM; Daubach EC; Romberger DJ; Thiele GM; Mikuls TR
    Front Immunol; 2023; 14():1203548. PubMed ID: 37654483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gingival tissue, an extrasynovial source of malondialdehyde-acetaldehyde adducts, citrullinated and carbamylated proteins.
    Bright R; Thiele GM; Manavis J; Mikuls TR; Payne JB; Bartold PM
    J Periodontal Res; 2018 Feb; 53(1):139-143. PubMed ID: 29044530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies to Malondialdehyde-Acetaldehyde Are Detected Prior to Rheumatoid Arthritis Diagnosis and After Other Disease Specific Autoantibodies.
    Mikuls TR; Edison J; Meeshaw E; Sayles H; England BR; Duryee MJ; Hunter CD; Kelmenson LB; Kay Moss L; Feser ML; Wagner B; Parish MC; Deane KD; Thiele GM
    Arthritis Rheumatol; 2020 Dec; 72(12):2025-2029. PubMed ID: 32621635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adduction of soluble proteins with malondialdehyde-acetaldehyde (MAA) induces antibody production and enhances T-cell proliferation.
    Willis MS; Klassen LW; Tuma DJ; Sorrell MF; Thiele GM
    Alcohol Clin Exp Res; 2002 Jan; 26(1):94-106. PubMed ID: 11821659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malondialdehyde-Acetaldehyde Modified (MAA) Proteins Differentially Effect the Inflammatory Response in Macrophage, Endothelial Cells and Animal Models of Cardiovascular Disease.
    Duryee MJ; Clemens DL; Opperman PJ; Thiele GM; Duryee LM; Garvin RP; Anderson DR
    Int J Mol Sci; 2021 Nov; 22(23):. PubMed ID: 34884754
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T cell proliferative responses to malondialdehyde-acetaldehyde haptenated protein are scavenger receptor mediated.
    Willis MS; Thiele GM; Tuma DJ; Klassen LW
    Int Immunopharmacol; 2003 Oct; 3(10-11):1381-99. PubMed ID: 12946435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Citrullinated Inhibitor of DNA Binding 1 Is a Novel Autoantigen in Rheumatoid Arthritis.
    Ohara RA; Edhayan G; Rasmussen SM; Isozaki T; Remmer HA; Lanigan TM; Campbell PL; Urquhart AG; Lawton JN; Chung KC; Fox DA; Ruth JH
    Arthritis Rheumatol; 2019 Aug; 71(8):1241-1251. PubMed ID: 30861322
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased immunogenicity to P815 cells modified with malondialdehyde and acetaldehyde.
    Duryee MJ; Klassen LW; Jones BL; Willis MS; Tuma DJ; Thiele GM
    Int Immunopharmacol; 2008 Aug; 8(8):1112-8. PubMed ID: 18550015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    England BR; Duryee MJ; Roul P; Mahajan TD; Singh N; Poole JA; Ascherman DP; Caplan L; Demoruelle MK; Deane KD; Klassen LW; Thiele GM; Mikuls TR
    Arthritis Rheumatol; 2019 Sep; 71(9):1483-1493. PubMed ID: 30933423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune Recognition of Citrullinated Proteoglycan Aggrecan Epitopes in Mice with Proteoglycan-Induced Arthritis and in Patients with Rheumatoid Arthritis.
    Markovics A; Ocskó T; Katz RS; Buzás EI; Glant TT; Mikecz K
    PLoS One; 2016; 11(7):e0160284. PubMed ID: 27466816
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subjects at-risk for future development of rheumatoid arthritis demonstrate a PAD4-and TLR-dependent enhanced histone H3 citrullination and proinflammatory cytokine production in CD14
    Okamato Y; Ghosh T; Okamoto T; Schuyler RP; Seifert J; Charry LL; Visser A; Feser M; Fleischer C; Pedrick C; August J; Moss L; Bemis EA; Norris JM; Kuhn KA; Demoruelle MK; Deane KD; Ghosh D; Holers VM; Hsieh EWY
    J Autoimmun; 2021 Feb; 117():102581. PubMed ID: 33310262
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Malondialdehyde-acetaldehyde antibody concentrations in rheumatoid arthritis and other rheumatic conditions.
    Mikuls TR; Duryee MJ; England BR; Anderson DR; Hearth-Holmes M; Su K; Michaud K; Payne JB; Sayles H; Hunter C; McGowan JD; Klassen LW; Thiele GM
    Int Immunopharmacol; 2018 Mar; 56():113-118. PubMed ID: 29414640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibodies against advanced glycation end-products and malondialdehyde-acetaldehyde adducts identify a new specific subgroup of hitherto patients with seronegative arthritis with a distinct clinical phenotype and an HLA class II association.
    van den Beukel MD; van Wesemael TJ; Hoogslag ATW; Borggreven NV; Huizinga TW; van der Helm-van Mil AH; Toes RE; van der Woude D; Trouw LA
    RMD Open; 2023 Dec; 9(4):. PubMed ID: 38053459
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Macrophage activation and inflammatory priming by anti-MAA antibodies in rheumatoid arthritis.
    Afonso M; Sun J; Sakuraba K; Cîrciumaru A; Lagutkin D; Filipović M; Catrina AI; Grönwall C; Hensvold A; Réthi B
    Clin Immunol; 2024 Aug; 265():110303. PubMed ID: 38969267
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis.
    Thiele GM; Duryee MJ; Dusad A; Hunter CD; Lacy JP; Anderson DR; Wang D; O'Dell JR; Mikuls TR; Klassen LW
    Int Immunopharmacol; 2012 Aug; 13(4):424-31. PubMed ID: 22626832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody responses to de novo identified citrullinated fibrinogen peptides in rheumatoid arthritis and visualization of the corresponding B cells.
    Joshua V; Schobers L; Titcombe PJ; Israelsson L; Rönnelid J; Hansson M; Catrina AI; Pruijn GJ; Malmström V
    Arthritis Res Ther; 2016 Dec; 18(1):284. PubMed ID: 27906052
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.